The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Three-Dimensional Models of Wild-Type and Mutated Forms of Cytochrome P450 14α-Sterol Demethylases from Aspergillus fumigatus and Candida albicans Provide Insights into Posaconazole Binding
Open accessAbstract
The cytochrome P450 sterol 14α-demethylase enzyme (CYP51) is the target of azole antifungals. Azoles block ergosterol synthesis, and thereby fungal growth, by binding in the active-site cavity of the enzyme and ligating the iron atom of the heme cofactor through a nitrogen atom of the azole. Mutations in and around the CYP51 active site have resulted in azole resistance. In this work, homology models of the CYP51 enzymes from Aspergillus fumigatus and Candida albicans were constructed based on the X-ray crystal structure of CYP51 from Mycobacterium tuberculosis . Using these models, binding modes for voriconazole (VOR), fluconazole (FLZ), itraconazole (ITZ), and posaconazole (POS) were predicted from docking calculations. Previous work had demonstrated that mutations in the vicinity of the heme cofactor had a greater impact on the binding of FLZ and VOR than on the binding of POS and ITZ. Our modeling data suggest that the long side chains of POS and ITZ occupy a specific channel within CYP51 and that this additional interaction, which is not available to VOR and FLZ, serves to stabilize the binding of these azoles to the mutated CYP51 proteins. The model also predicts that mutations that were previously shown to specifically impact POS susceptibility in A. fumigatus and C. albicans act by interfering with the binding of the long side chain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comparative Protein Modelling by Satisfaction of Spatial Restraints
Šali, A., & Blundell, T. L. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1626 · Cited by 12,977
Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. Cohen
Jones, G., Willett, P., Glen, R. C., Leach, A. R., & Taylor, R. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0897 · Cited by 6,763
Current and emerging azole antifungal agents
Sheehan, D. J., Hitchcock, C. A., & Sibley, C. M. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.1.40 · Cited by 1,137
Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences
Sanglard, D., & Odds, F. C. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00181-0 · Cited by 784
Mammalian Microsomal Cytochrome P450 Monooxygenase
Williams, P. A., Cosme, J., Sridhar, V., Johnson, E. F., & McRee, D. E. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80408-6 · Cited by 696
Podust, L. M., Poulos, T. L., & Waterman, M. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061562898 · Cited by 531
Li, H., & Poulos, T. L. (1997) · Nature Structural Biology · doi:10.1038/nsb0297-140 · Cited by 465
Large-scale protein structure modeling of the Saccharomyces cerevisiae genome
Sánchez, R., & Sali, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13597 · Cited by 362
Advances in comparative protein-structure modelling
Sánchez, R., & Šali, A. (1997) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(97)80027-9 · Cited by 329
Mellado, E., Diaz-Guerra, T. M., Cuenca-Estrella, M., & Rodriguez-Tudela, J. L. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.7.2431-2438.2001 · Cited by 307
Diaz-Guerra, T. M., Mellado, E., Cuenca-Estrella, M., & Rodriguez-Tudela, J. L. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.1120-1124.2003 · Cited by 281
Nascimento, A. M., Goldman, G. H., Park, S., Marras, S. A. E., Delmas, G., Oza, U., Lolans, K., Dudley, M. N., Mann, P. A., & Perlin, D. S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.5.1719-1726.2003 · Cited by 258
Ji, H., Zhang, W., Zhou, Y., Zhang, M., Zhu, J., Song, Y., Lü, J., & Zhu, J. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990589g · Cited by 213
How Similar Are P450s and What Can Their Differences Teach Us?
Graham, S. E., & Peterson, J. A. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1350 · Cited by 203
Mann, P. A., Parmegiani, R. M., Wei, S.-Q., Mendrick, C. A., Li, X., Loebenberg, D., DiDomenico, B., Hare, R. S., Walker, S. S., & McNicholas, P. M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.2.577-581.2003 · Cited by 189
Self-citationWester, M. R., Johnson, E. F., Marques-Soares, C., Dansette, P. M., Mansuy, D., & Stout, C. D. (2003) · Biochemistry · doi:10.1021/bi0273922 · Cited by 180
Anti-CandidaDrugs — The Biochemical Basis for Their Activity
BOSSCHE, H. V., Willemsens, G., & Marichal, P. (1987) · CRC Critical Reviews in Microbiology · doi:10.3109/10408418709104448 · Cited by 146
Pfaller, M. A., Messer, S. A., Hollis, R. J., & Jones, R. N. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.10.2862-2864.2001 · Cited by 146
Manavathu, E. K. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.2.229 · Cited by 141
A close family resemblance: the importance of structure in understanding cytochromes P450
Peterson, J. A., & Graham, S. E. (1998) · Structure · doi:10.1016/s0969-2126(98)00109-9 · Cited by 136
Macchiarulo, A., Costantino, G., Fringuelli, D., Vecchiarelli, A., Schiaffella, F., & Fringuelli, R. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(02)00263-8 · Cited by 109
Genetic Basis for Differential Activities of Fluconazole and Voriconazole against Candida krusei
Fukuoka, T., Johnston, D. A., Winslow, C. A., de Groot, M. J., Burt, C., Hitchcock, C. A., & Filler, S. G. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1213-1219.2003 · Cited by 109
Changes in susceptibility to posaconazole in clinical isolates of Candida albicans
Li, X., Brown, N., Chau, A. S., López-Ribot, J. L., Ruesga, M. T., Quindos, G., Mendrick, C. A., Hare, R. S., Loebenberg, D., DiDomenico, B., et al. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh027 · Cited by 97
Self-citationPoulos, T. L. (1995) · Current Opinion in Structural Biology · doi:10.1016/0959-440x(95)80009-3 · Cited by 79
Podust, L. M., Stojan, J., Poulos, T. L., & Waterman, M. R. (2001) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(01)00388-9 · Cited by 70
Modeling cytochrome P450 14α demethylase (Candida albicans) from P450cam
Boscott, P. E., & Grant, G. H. (1994) · Journal of Molecular Graphics · doi:10.1016/0263-7855(94)80086-3 · Cited by 63
Lewis, D. F., Wiseman, A., & Tarbit, M. H. (1999) · Journal of enzyme inhibition · doi:10.3109/14756369909030315 · Cited by 32
Höltje, H., & Fattorusso, C. (1998) · Pharmaceutica Acta Helvetiae · doi:10.1016/s0031-6865(97)00036-8 · Cited by 27
Cited by
Epidemiology of Invasive Mycoses in North America
Pfaller, M. A., & Diekema, D. J. (2010) · Critical Reviews in Microbiology · doi:10.3109/10408410903241444 · Cited by 901
Howard, S. J., Cerar, D., Anderson, M. J., Albarrag, A., Fisher, M. C., Pasqualotto, A. C., Laverdiere, M., Arendrup, M. C., Perlin, D. S., & Denning, D. W. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1507.090043 · Cited by 750
Mechanisms of Antifungal Drug Resistance
Cowen, L. E., Sanglard, D., Howard, S. J., Rogers, P. D., & Perlin, D. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019752 · Cited by 647
Resistance to Antifungal Agents: Mechanisms and Clinical Impact
Kanafani, Z. A., & Perfect, J. R. (2008) · Clinical Infectious Diseases · doi:10.1086/524071 · Cited by 619
Efflux-Mediated Antifungal Drug Resistance
Cannon, R. D., Lamping, E., Holmes, A. R., Niimi, K., Baret, P. V., Keniya, M. V., Tanabe, K., Niimi, M., Goffeau, A., & Monk, B. C. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00051-08 · Cited by 608
Metadata
- Authors
- Xiao, L., Madison, V., Chau, A. S., Loebenberg, D., Palermo, R. E., & McNicholas, P. M.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2004-02
- Volume
- 48
- Issue
- 2
- Pages
- 568-574
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2126944876
- Cited by
- 267
- References
- 28
- FWCI
- 10.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.